Prosecution Insights
Last updated: November 04, 2026
Application No. 18/958,319

MYOPIA OCULAR PREDICTIVE TECHNOLOGY AND INTEGRATED CHARACTERIZATION SYSTEM

Non-Final OA §103§DOUBLEPATENT
Filed
Nov 25, 2024
Priority
Jul 19, 2024 — continuation of 12/274,503
Examiner
CHOUDHURY, MUSTAK
Art Unit
2872
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Cognitivecare Inc.
OA Round
1 (Non-Final)
85%
Grant Probability
Favorable
1-2
OA Rounds
7m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
705 granted / 830 resolved
+16.9% vs TC avg
Strong +21% interview lift
Without
With
+21.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
21 currently pending
Career history
858
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
57.1%
+17.1% vs TC avg
§102
19.9%
-20.1% vs TC avg
§112
15.6%
-24.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 830 resolved cases

Office Action

§103 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement (IDS) submitted on 11/25/2024 has been considered by the examiner. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1, 7-11, 16 and 20 rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1, 10, 16 and 19 and 15 of U.S. Patent No. 12,274,502. Although the claims at issue are not identical, they are not patentably distinct from each other because all limitations of independent claims 1, 16 and 20 from the instant invention are to be found independent claims 1, 16 and 19 of U.S. Patent No. 12,274,502, except for minor difference(s), for example “a real-time feedback” instead of “a first and a second feedback” or “the machine learning model is a pre-trained model with a data set comprising the input data and the behavioral data from plurality of patients” instead of “the machine learning model is a pre-trained model with a data set comprising the input data from plurality of patients”. It is clear that all the elements of the instant application as claimed are to be found in patent claim(s) (as the patent claim(s) fully encompasses the application claim(s)). The difference between the application claim(s) and the patent claim(s) lies in the fact that the patent claim includes more elements and is thus much more specific. Thus, the invention of claims of the patent is in effect a “species” of the “generic” invention of the application claims. It has been held that the generic invention is “anticipated” by the “species”. See In re Goodman, 29 USPQ2d 2010 (Fed. Cir. 1993). Since the claims of the instant application are anticipated by the claims of the patent 12,274,502, thereby the instant invention is not patentably distinct, where both inventions are directed to: “eye health prediction and more specifically to systems and methods for myopia prognosis powered by multimodal data for detecting myopia in an individual and its progression over time or risk of developing myopia in case the individual does not currently have myopia at the time of eye test.”. Table shows the list of conflicting claims: Claims from the instant application 18958319 Claims from application 18778027 now patent 12,274,502 Claims 1 + 7-10. Claim 1. Claim 11. Claim 10. Claim 16. Claim 16. Claim 20. Claim 20. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-20 are rejected under 35 U.S.C. 103 as being unpatentable over LI et al. (US PUB 2021/0375460; herein after “Li”) in view of Tran (US PUB 2022/0248955). Li and Tran disclose predictions or diagnoses of myopia progression. Therefore, they are analogous art. Regarding claim 1, Li teaches a system (i.e., a computer-implemented system, para. [0010]) comprising: a processor storing instructions in non-transitory memory that, when executed, cause the processor to: receive (i.e., an electronic device comprising: a processor, a memory, and an operating system configured to perform executable instructions, para. [0010]), via an input module (e.g., the input device (module) is a touch screen or a multi-touch screen, para. [0068]), an input data, wherein the input data comprises ocular characteristics of an ocular region of a user (i.e., imaging one or both eyes of the individual, screening for ocular disorders or conditions (e.g., ocular characteristics), para. [0013], also see para. [0014], and clinical data of the user (i.e., a software module obtaining data of the individual (clinical data), para. [0010]; a) obtaining input data of the individual, para. [0012]); receive behavioral data comprising one or more of device screen exposure time (i.e., the algorithms and models disclosed herein can provide clinically meaningful predictions of refractive error over various time spans (screen time), para. [0051]), and outdoor activity metrics (i.e., the data comprises average exposure to sunlight or natural lighting (e.g., outdoor activities, para. [0008]), para. [0013]); combine, using a multimodal fusion module, the input data and the behavioral data to determine a holistic health embedding (i.e., b) a software module (a multimodal fusion module) evaluating the input data using a machine learning model to generate a prediction of myopia onset or myopia progression, para. [0014]; Artificial Intelligence (AI) has the potential to revolutionize disease diagnosis and prediction, leading to an overall (holistic) higher standard of care, para. [0080], also see para. [0050]); determine, based on a machine learning model and the holistic health embedding, a risk category of myopia and severity of myopia for the user (i.e., the machine learning model is a linear model providing a relationship between myopia progression and two or more features corresponding to the input data, para. [0012]); determine, based on the machine learning model and the holistic health embedding, influence of features of the input data and the behavioral data on myopia (i.e., b) a software module evaluating the input data using a machine learning model to generate a prediction of myopia onset or myopia progression, para. [0014]); recommend, by the machine learning model, based on the risk category of myopia and the severity of myopia (i.e., a new avenue for prediction of visual outcomes in populations with high myopia prevalence while identifying individuals at risk for developing high myopia, para. [0051]), personalized care interventions via a real-time feedback (i.e., prediction accuracy is assessed (feedback) via area under the receiver operating characteristics curve (AUC), para. [0050]), wherein personalized care interventions comprise a change in the behavioral data; and monitor continuously, for an effectiveness of the personalized care interventions on myopia (i.e., when high myopia is not predicted (e.g., the individual is classified into a lower risk category), the recommendation is provided for prevention (e.g., lifestyle changes), para. [0058]); and wherein the machine learning model is a pre-trained model with a data set comprising the input data and the behavioral data from plurality of patients to recognize one or more patterns using the holistic health embedding (i.e., the model accurately predicts myopia progression and high myopia onset (pattern) and shows any differences in progression rates between patients who sought interventive methods such as OK lens, and atropine, respectively, para. [0080]); and wherein the system is configured for myopia management powered by multimodal data (i.e., Through predicting myopia progression, the current rapid prevalence rates can be dampened (e.g., myopia management) by interventive techniques (e.g., by multimodal data), para. [0080]). Li teaches all limitations except for explicit teaching of receive behavioral data comprising one or more of device screen exposure time; personalized care interventions via a real-time feedback; and combine, using a multimodal fusion module, the input data and the behavioral data to determine a holistic health embedding. However, in a related field of endeavor Tran teaches the analysis may be automated, and may also be capable of providing real-time feedback to patients and/or healthcare providers (para. [0272]). a patient or healthcare provider may create a patient profile comprising, e.g., identifying, characterizing, and/or medical information, including information about a patient's medical history, profession, and/or lifestyle. Further examples of information that may be stored in a patient profile includes diagnostic information such as family medical history, medical symptoms, duration of hypertension, localized vs. general hypertension, etc. Further contemplated as part of a patient profile are non-pharmacologic treatment(s) (e.g., chiropractic, radiation, holistic, psychological, acupuncture, etc.), lifestyle characteristics (e.g., diet, alcohol intake, smoking habits), cognitive condition, behavioral health, and social well-being (para. [0256]). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of Li such that the analysis may be capable of providing real-time feedback to a patient and the patient may create a patient profile comprising, e.g., a holistic lifestyle characteristic that includes diagnostic information such as family medical history, cognitive condition, behavioral health (e.g., screen time), as taught by Tran such that the technology will provide improved field-care capabilities, reduce recovery time of injured people, and help minimize complications of wound healing after trauma or surgery. Regarding claim 2, Li according to claim 1 further teaches the system further receives via a wearable device, real-time data capture of latent characteristics influencing myopia comprising blink rate, gaze direction, and ambient light exposure (i.e., the data comprises average exposure to sunlight or natural lighting, intensity of sunlight exposure, average UV index, latitude, or any combination thereof, para. [0009]). Regarding claim 3, Li according to claim 1 further teaches the behavioral data further comprises lifestyle factors, wherein the lifestyle factors comprise, one or more of diet, physical activity, sitting posture, smoking, alcohol consumption, and sedentary lifestyle (i.e., given a prediction of myopia onset when myopia has not yet occurred or when myopia is in the early stages, a recommended prevention step may be lifestyle changes such as increasing outdoor activities or exposure to sunlight, or reducing near-work such as reading, para. [0008]). Regarding claim 4, Li according to claim 1 further teaches the behavioral data further comprises social determinants of health factors, wherein social determinants of health factors comprise one or more of age, ethnicity, gender, geography, exposure to pollution, and exposure to green spaces (i.e., the input data is obtained from an eye examination. In some embodiments, the input data comprises age, gender, nationality, ethnicity, spherical equivalent (SE) measurement of one or both eyes, para. [0012]). Regarding claim 5, Li according to claim 1 further teaches the behavioral data further comprise screen distance from eyes (i.e., a recommended prevention step may be lifestyle changes such as increasing outdoor activities or exposure to sunlight, or reducing near-work (distance) such as reading, para. [0008]), screen brightness settings used by the patients, screen size used, and screen size variations within a day (i.e., the portal is displayed on a digital screen of the electronic device, the electronic device comprises an analog interface, the electronic device comprises a digital interface such as a touchscreen (e.g., larger screen size), para. [0063]; the digital processing device is part of a point-of-care device such as a medical diagnostic device integrating the diagnostic software described herein, the medical diagnostic device is a consumer-facing portable medical diagnostic device configured for use outside of the clinical setting (e.g. consumer use at home such as on a smart phone app), para. [0064]). Regarding claim 6, Li according to claim 1 further teaches the personalized care interventions comprise time limits on screen use, reduced brightness of screen, promoting outdoor activities, implementing regular eye breaks during near work, and providing guidance on reducing screen time (i.e., given a prediction of myopia onset when myopia has not yet occurred or when myopia is in the early stages, a recommended prevention step may be lifestyle changes such as increasing outdoor activities or exposure to sunlight, or reducing near-work such as reading, para. [0008]). Regarding claim 7, Li according to claim 1 further teaches the ocular characteristics comprise one or more of Optic Disc Size, Cup Disc Ratio, Optic Disc, Fundus, IOP, Ocular Alignment, Tor CA unaided, BCVA, SPH, Cyl, Tor fr corr axis (i.e., the further testing comprises an optometry exam, genetic testing, imaging one or both eyes of the individual, screening for ocular disorders or conditions (e.g., Ocular Alignment), or any combination thereof., para. [0010]) Regarding claim 8, Li according to claim 1 further teaches the input data further comprises an image of the ocular region and an image processing module comprising adaptive filtering techniques is used to extract the ocular characteristics (i.e., a software module processing the data to calculate a spherical equivalent based on the refraction … imaging one or both eyes of the individual, screening for ocular disorders, para. [0011]). Regarding claim 9, Li according to claim 1 further teaches the system further detects, based on the machine learning model and the holistic health embedding, a first output, wherein the first output comprises likelihood of myopia, and severity of myopia severity (i.e., the prediction comprises a likelihood of progression to a higher degree of myopia, para. [0011] … a machine learning model to generate a prediction of myopia onset or myopia progression, para. [0012]). Regarding claim 10, Li according to claim 1 further teaches the system further predicts, based on the machine learning model and the holistic health embedding, a second output, wherein the second output comprises an onset of myopia and a progression of myopia in the user (i.e., a machine learning model to generate a prediction of myopia onset or myopia progression, para. [0012] … different degrees of myopic severity, para. [0115]). Regarding claim 11, Li according to claim 1 further teaches the machine learning model comprises one or more of logistic regressions, support vector machines (SVM), K-nearest neighbors, decision trees, and ensemble models; and wherein the ensemble model comprises one or more of random forests, extra trees, and bagging (SVM, para. [0057]). Regarding claim 12, Li according to claim 1 further teaches the system further generates an eye examination appointment schedule based on the risk category of myopia and severity of myopia (i.e., Predicting High Myopia has been associated with a range of comorbidities, such as glaucoma and maculopathy, further elevating the severity of the disease, para. [0142] and [0143] … carrying different degrees of myopic severity with a number of candidate genes associated to the disease, para. [0115]). Regarding claim 13, Li according to claim 1 further teaches the system further comprises a generative artificial intelligence (AI) module configured to preprocess and enhance quality of the multimodal (para. [0003] and [0080]). Regarding claim 14, Li according to claim 13 further teaches the generative artificial intelligence module enhances an understanding of input fields by context-specific explanations (para. [0080]). Regarding claim 15, Li according to claim 13 further teaches the generative artificial intelligence module is integrated and interfaced with a graphical user interface to produce dynamic visualizations and narrative summaries that explain predictions from the machine learning model in an intuitive manner configured to interpret complex data sets for making informed decisions (para. [0080]). Regarding claim 16, Li according to claim 1 further teaches a method (see para. [0003]) comprising, receiving, via an input module, an input data, wherein the input data comprises ocular characteristics of an ocular region of a user, and clinical data of the user; receiving behavioral data comprising one or more of device screen exposure time, and outdoor activity metrics; combining, using a multimodal fusion module, the input data and the behavioral data to determine a holistic health embedding; determining, based on a machine learning model and the holistic health embedding, a risk category of myopia and severity of myopia for the user; determining, based on the machine learning model and the holistic health embedding, influence of features of the input data and the behavioral data on myopia; recommending, by the machine learning model, based on the risk category of myopia and the severity of myopia, personalized care interventions via a real-time feedback, wherein personalized care interventions comprise a change in the behavioral data; and monitoring continuously, for an effectiveness of the personalized care interventions on myopia; and wherein the machine learning model is a pre-trained model with a data set comprising the input data and the behavioral data from plurality of patients to recognize one or more patterns using the holistic health embedding; and wherein the method is configured for myopia management powered by multimodal data (see para. [0012], [0047], and for the same reasons as set forth in claim 1 above). Regarding claim 17, Li according to claim 16 further teaches the behavioral data further comprises lifestyle factors and social determinants of health factors, wherein the lifestyle factors comprise, one or more of diet, physical activity, sitting posture, smoking, alcohol consumption, and sedentary lifestyle; and wherein social determinants of health factors comprise one or more of age, ethnicity, gender, geography, exposure to pollution, and exposure to green spaces (i.e., the input data is obtained from an eye examination. In some embodiments, the input data comprises age, gender, nationality, ethnicity, spherical equivalent (SE) measurement of one or both eyes, para. [0012]). Regarding claim 18, Li according to claim 16 further teaches the behavioral data further comprise screen distance from eyes (i.e., a recommended prevention step may be lifestyle changes such as increasing outdoor activities or exposure to sunlight, or reducing near-work (distance) such as reading, para. [0008]), screen brightness settings used by the patients, screen size used, and screen size variations within a day (i.e., the portal is displayed on a digital screen of the electronic device, the electronic device comprises an analog interface, the electronic device comprises a digital interface such as a touchscreen (e.g., larger screen size), para. [0063]; the digital processing device is part of a point-of-care device such as a medical diagnostic device integrating the diagnostic software described herein, the medical diagnostic device is a consumer-facing portable medical diagnostic device configured for use outside of the clinical setting (e.g. consumer use at home such as on a smart phone app), para. [0064]). Regarding claim 19, Li according to claim 16 further teaches the personalized care interventions comprise time limits on screen use, reduced brightness of screen, promoting outdoor activities, implementing regular eye breaks during near work, and providing guidance on reducing screen time (i.e., given a prediction of myopia onset when myopia has not yet occurred or when myopia is in the early stages, a recommended prevention step may be lifestyle changes such as increasing outdoor activities or exposure to sunlight, or reducing near-work such as reading, para. [0008]). Regarding claim 20, Li according to claim 1 further teaches a non-transitory computer-readable medium having stored thereon instructions executable by a computer system to perform operations (see para. [0046]) comprising: receiving, via an input module, an input data, wherein the input data comprises ocular characteristics of an ocular region of a user, and clinical data of the user; receiving behavioral data comprising one or more of device screen exposure time, and outdoor activity metrics; combining, using a multimodal fusion module, the input data and the behavioral data to determine a holistic health embedding; determining, based on a machine learning model and the holistic health embedding, a risk category of myopia and severity of myopia for the user; determining, based on the machine learning model and the holistic health embedding, influence of features of the input data and the behavioral data on myopia; recommending, by the machine learning model, based on the risk category of myopia and the severity of myopia, personalized care interventions via a real-time feedback, wherein personalized care interventions comprise a change in the behavioral data; and monitoring continuously, for an effectiveness of the personalized care interventions on myopia; and wherein the machine learning model is a pre-trained model with a data set comprising the input data and the behavioral data from plurality of patients to recognize one or more patterns using the holistic health embedding; and wherein the instructions are configured for myopia management powered by multimodal data (see para. [0011], [0014], and for the same reasons as set forth in claim 1 above). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. LI et al. (US PUB 2022/0165418) teaches “the plurality of disorder classifications further comprise at least one of a cataract, myopia, kidney disease, hypertension, or stroke.”, paragraph 0015. Serafini et al. (US PUB 2022/0165418) teaches “The machine-learning algorithms may include performing at least one of the following: optimization of the interchangeable modules and examination order, analysis of images to determine ocular pathology ranging from true physiologic deficit pathologies, contrast sensitivity, oculomotor function, visual acuity, myopia vs hyperopia screening etc.”, paragraph 0020. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MUSTAK CHOUDHURY whose telephone number is (571)272-5247. The examiner can normally be reached on M-F 8AM-5PM EST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ricky Mack can be reached on (571)272-2333. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MUSTAK CHOUDHURY/Primary Examiner, Art Unit 2872 August 26, 2026
Read full office action

Prosecution Timeline

Nov 25, 2024
Application Filed
Sep 01, 2026
Non-Final Rejection mailed — §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12780374
REMOVABLE READING GLASSES FOR A DIVING MASK OR GOGGLES
3y 9m to grant Granted Nov 03, 2026
Patent 12782703
Apparatus, Optical system, and Method for digital holographic and polarization microscopy
3y 11m to grant Granted Nov 03, 2026
Patent 12782698
SCANNING DEVICE AND ISCAT CONFOCAL MICROSCOPE SYSTEM
2y 11m to grant Granted Nov 03, 2026
Patent 12782764
OPTICAL ISOLATOR, ULTRAVIOLET LASER APPARATUS, AND ELECTRONIC DEVICE MANUFACTURING METHOD
2y 11m to grant Granted Nov 03, 2026
Patent 12765775
Method for determining the autofluorescence of an ocular fundus of an eye by means of optical coherence tomography
2y 10m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
85%
Grant Probability
99%
With Interview (+21.0%)
2y 6m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 830 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month